Artificial lung and extracorporeal gas exchange

Panminerva Medica

Volumn 47, Issue 1, 2005, Pages 11-17

  Bensberg, R ^a   Dembinski, R ^a   Kopp, R ^a   Kuhlen, R ^a  

^a UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

Author keywords

Artificial organs; Extracorporeal lung assist device; Lung

Indexed keywords

ANIMAL; ARTICLE; ARTIFICIAL ORGAN; EXTRACORPOREAL OXYGENATION; HUMAN; INSTRUMENTATION; LUNG; METHODOLOGY; OXYGENATOR;

ANIMALS; ARTIFICIAL ORGANS; EXTRACORPOREAL MEMBRANE OXYGENATION; HUMANS; LUNG; OXYGENATORS;

EID: 22144442075     PISSN: 00310808     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Bartlett RH, Roloff DW, Custer JR, Younger JG, Hirschl RB. Extracorporeal life support. The University of Michigan experience. JAMA 2000;283:904-8.
2. Mols G, Loop T, Geiger K, Farthmann E, Benzing A. Extracorporeal membrane oxygenation: a ten-year experience. Am J Surg 2000;180:144-54.
3. Peek GJ, Moore HM, Moore N, Sosnowski AW, Firmin RK. Extracorporeal membrane oxygenation for adult respiratory failure. Chest 1997;112:759-64.
4. Lewandowski K, Rossaint R, Pappert D, Gerlach H, Slama KJ, Weidemann H et al. High survival rate in 122 ARDS patients managed according to a clinical algorithm including extracorporeal membrane oxygenation. Intensive Care Med 1997;23:819-35.
5. Linden V, Palmer K, Reinhard J, Westman R, Ehren H, Granholm T et al. High survival in adult patients with acute respiratory distress syndrome treated by extracorporeal membrane oxygenation, minimal sedation, and pressure supported ventilation. Intensive Care Med 2000;26:1630-7.
6. Ullrich R, Lorber C, Roder G, Urak G, Faryniak B, Sladen RN et al. Controlled airway pressure therapy, nitric oxide inhalation, prone position, and extracorporeal membrane oxygenation (ECMO) as components of an integrated approach to ARDS. Anesthesiology 1999;91:1577-86.
7. Zapol WM, Snider MT, Hill JD, Fallat RJ, Bartlett RH, Edmunds LH et al. Extracorporeal membrane oxygenation in severe acute respiratory failure. A randomized prospective study. JAMA 1979;242:2193-6.
8. 2 removal for adult respiratory distress syndrome. Am J Respir Crit Care Med 1994;149(2 Pt 1):295-305.
9. Ashbaugh DG, Bigelow DB, Petty TL, Levine BE. Acute respiratory distress in adults. Lancet 1967;2:319-23.
10. Murray JF, Matthay MA, Luce JM, Flick MR. An expanded definition of the adult respiratory distress syndrome. Am Rev Respir Dis 1988;138:720-3.
11. Bernard GR, Artigas A, Brigham KL, Carlet J, Falke K, Hudson L et al. The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med 1994;149(3 Pt 1):818-24.
12. Lewandowski K. Extracorporeal membrane oxygenation for severe acute respiratory failure. Crit Care 2000;4:156-68.
13. Jardin F, Fellahi JL, Beauchet A, Vieillard-Baron A, Loubieres Y, Page B. Improved prognosis of acute respiratory distress syndrome 15 years on. Intensive Care Med 1999;25:936-41.
14. Kopp R, Kuhlen R, Max M, Rossaint R. Evidence-based medicine in the therapy of the acute respiratory distress syndrome. Intensive Care Med 2002;28:244-55.
15. Gibbon JH. Artificial maintance of circulation during experimental occlusion of pulmonary artery. Arch Surg 1937;34:1105-31.
16. Hemmila MR, Rowe SA, Boules TN, Miskulin J, McGillicuddy JW, Schuerer DJ et al. Extracorporeal life support for severe acute respiratory distress syndrome in adults. Ann Surg 2004;240:595-605.
17. UK Collaborative ECMO Trail Group. UK collaborative randomised trial of neonatal extracorporeal membrane oxygenation. Lancet 1996;348:75-82.
18. Pappert D, Rossaint R, Gerlach H, Falke KJ. Extracorporeal membrane oxygenation. In: Evans TW, Haslet C editors. ARDS Acute respiratory distres syndrome. London: Chapman & Hall; 1996.p.425-37.
19. Koster A, Sanger S, Hansen R, Sodian R, Mertzlufft F, Harke C et al. Prevalence and persistence of heparin/platelet factor 4 antibodies in patients with heparin coated and noncoated ventricular assist devices. ASAIO J 2000;46:319-22.
20. Cruz D, Karlsberg R, Takano Y, Vora D, Tobis J. Subacute stent thrombosis associated with a heparin-coated stent and heparin-induced thrombocytopenia. Catheter Cardiovasc Interv 2003;58:80-3.
21. Peek GJ, Killer HM, Reeves R, Sonowski AW, Firmin RK. Early experience with a polymethyl pentene oxygenator for adult extracorporeal life support. ASAIO J 2002;48:480-2.
22. Dembinski R, Kopp R, Henzler D, Hochhausen N, Oslender N, Max M et al. Extracorporeal gas exchange with the DeltaStream rotary blood pump in experimental lung injury. Artif Organs 2003;27:530-6.
23. Wendel HP, Ziemer G. Coating-techniques to improve the hemocompatibility of artificial devices used for extracorporeal circulation. Eur J Cardiothorac Surg 1999;16:342-50.
24. Annich GM, Meinhardt JP, Mowery KA, Ashton BA, Merz SI, Hirschl RB et al. Reduced platelet activation and thrombosis in extracorporeal circuits coated with nitric oxide release polymers. Crit Care Med 2000;28:915-20.
25. Conrad SA, Zwischenberger JB, Grier LR, Alpard SK. Bidani A. Total extracorporeal arteriovenous carbon dioxide removal in acute respiratory failure: a phase I clinical study. Intensive Care Medicine 2001;27:1340-51.
26. Philipp A, Reng MC, Kaiser M, Kaiser M, Pfeifer M, Aebert H et al. Arterio-venöse pumpenlose extrakorporale Lungenunterstützung als neues Verfahren bei der Behandlung des Lungenversagens. Kardiotechnik 1999;1:3-7.
27. Liebold A, Reng MC, Philipp A, Pfeifer M, Birnbaum DE. Pumpless extracorporeal lung assist - experience with the first 20 cases. Euro J Cardiothorac Surg 2000;17:608-13.
28. Reng M, Philipp A, Kaiser M, Pfeifer M, Gruene S, Schoelmerich J. Pumpless extracorporeal lung assist and adult respiratory distress syndrome. Lancet 2000;356:219-20.
29. Philipp A, Foltan M, Gietl M, Reng M, Liebold A, Kobuch R et al. Interventionelle extrakorporale Lungenunterstützung (ILA) mittels arterio-venösem Shunt und einem neu entwickelten Low Resistance Lung Assist Device (LAD). Kardiotechnik 2003;12:7-12.
30. Zwischenberger JB, Wang DF, Lick SD, Deyo DJ, Alpard SK, Chambers SD. The paracorporeal artificial lung improves 5-day outcomes from lethal smoke/burn-induced acute respiratory distress syndrome in sheep. Ann Thorac Surg 2002;74:1011-6.